… discusses his outlook for the U.K., post-Brexit vote. He speaks from the Allen & Co. Sun Valley Conference in Sun Valley, Idaho. (Source: Bloomberg)
See Original Article

When Bloomberg News asked the company if the $30 billion figure referred to talazoparib alone or to all drugs in its class, known as PARP inhibitors,
See Original Article

Bottom line: Political uncertainties due to Brexit and European bank's recapitalization needs put the EUR under moderate selling pressure.
See Original Article

When it comes to unicorns, the rich are getting richer — and that's not great for young startups. Unicorns, or privately held companies valued at $1 billion or more, are continuing to raise large amounts of funding from investors.
See Original Article

In May, shortly before he spoke to Congress in Washington, Indian Prime Minister Narendra Modi traveled to Tehran to sign a deal with the leaders of
See Original Article